組換型ヒト血清アルブミンの世界市場インサイト・予測(~2025年)

QYResearchが発行した調査報告書(QYR20FB13001)
◆英語タイトル:Global Recombinant Human Serum Albumin Market Insights, Forecast to 2025
◆商品コード:QYR20FB13001
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年12月11日(※2024年版があります。お問い合わせください。)
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界の組換型ヒト血清アルブミン市場について調査・分析し、以下の構成でお届け致します。組換型ヒト血清アルブミンの種類別には、OsrHSA、ScrHSAに、用途別には、細胞培養培地、医療用サプリメント、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別組換型ヒト血清アルブミン売上データ
・地域別組換型ヒト血清アルブミン市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別組換型ヒト血清アルブミン市場規模:OsrHSA、ScrHSA
・用途別組換型ヒト血清アルブミン市場規模:細胞培養培地、医療用サプリメント、その他
・主要メーカーの企業情報:Albumedix、Merck、Ventria (InVitria)、NCPC、Oryzogen、HiMedia
・組換型ヒト血清アルブミンの市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...
【レポートの概要】

The global Recombinant Human Serum Albumin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Human Serum Albumin market based on company, product type, end user and key regions.
This report studies the global market size of Recombinant Human Serum Albumin in key regions like North America, Europe, China and Japan, focuses on the consumption of Recombinant Human Serum Albumin in these regions.
This research report categorizes the global Recombinant Human Serum Albumin market by top players/brands, region, type and end user. This report also studies the global Recombinant Human Serum Albumin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia

Recombinant Human Serum Albumin market size by Type
OsrHSA
ScrHSA

Recombinant Human Serum Albumin market size by Applications
Cell Culture Media
Medical Supplements
Other

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Recombinant Human Serum Albumin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Recombinant Human Serum Albumin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Recombinant Human Serum Albumin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Recombinant Human Serum Albumin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Recombinant Human Serum Albumin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Human Serum Albumin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 Recombinant Human Serum Albumin Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Recombinant Human Serum Albumin Market Size Growth Rate by Type
1.4.2 OsrHSA
1.4.3 ScrHSA
1.5 Market by Application
1.5.1 Global Recombinant Human Serum Albumin Market Size Growth Rate by Application
1.5.2 Cell Culture Media
1.5.3 Medical Supplements
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Recombinant Human Serum Albumin Market Size
2.1.1 Global Recombinant Human Serum Albumin Revenue 2014-2025
2.1.2 Global Recombinant Human Serum Albumin Sales 2014-2025
2.2 Recombinant Human Serum Albumin Growth Rate by Regions
2.2.1 Global Recombinant Human Serum Albumin Sales by Regions
2.2.2 Global Recombinant Human Serum Albumin Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Recombinant Human Serum Albumin Sales by Manufacturers
3.1.1 Recombinant Human Serum Albumin Sales by Manufacturers
3.1.2 Recombinant Human Serum Albumin Sales Market Share by Manufacturers
3.2 Recombinant Human Serum Albumin Revenue by Manufacturers
3.2.1 Recombinant Human Serum Albumin Revenue by Manufacturers (2014-2019)
3.2.2 Recombinant Human Serum Albumin Revenue Share by Manufacturers (2014-2019)
3.3 Recombinant Human Serum Albumin Price by Manufacturers
3.4 Recombinant Human Serum Albumin Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Human Serum Albumin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Human Serum Albumin Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Human Serum Albumin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Recombinant Human Serum Albumin Sales by Type
4.2 Global Recombinant Human Serum Albumin Revenue by Type
4.3 Recombinant Human Serum Albumin Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Recombinant Human Serum Albumin Breakdown Data by Application

6 North America
6.1 North America Recombinant Human Serum Albumin by Country
6.1.1 North America Recombinant Human Serum Albumin Sales by Country
6.1.2 North America Recombinant Human Serum Albumin Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Recombinant Human Serum Albumin by Type
6.3 North America Recombinant Human Serum Albumin by Application

7 Europe
7.1 Europe Recombinant Human Serum Albumin by Country
7.1.1 Europe Recombinant Human Serum Albumin Sales by Country
7.1.2 Europe Recombinant Human Serum Albumin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Recombinant Human Serum Albumin by Type
7.3 Europe Recombinant Human Serum Albumin by Application

8 Asia Pacific
8.1 Asia Pacific Recombinant Human Serum Albumin by Region
8.1.1 Asia Pacific Recombinant Human Serum Albumin Sales by Region
8.1.2 Asia Pacific Recombinant Human Serum Albumin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Recombinant Human Serum Albumin by Type
8.3 Asia Pacific Recombinant Human Serum Albumin by Application

9 Central & South America
9.1 Central & South America Recombinant Human Serum Albumin by Country
9.1.1 Central & South America Recombinant Human Serum Albumin Sales by Country
9.1.2 Central & South America Recombinant Human Serum Albumin Revenue by Country
9.1.3 Brazil
9.2 Central & South America Recombinant Human Serum Albumin by Type
9.3 Central & South America Recombinant Human Serum Albumin by Application

10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Serum Albumin by Country
10.1.1 Middle East and Africa Recombinant Human Serum Albumin Sales by Country
10.1.2 Middle East and Africa Recombinant Human Serum Albumin Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Recombinant Human Serum Albumin by Type
10.3 Middle East and Africa Recombinant Human Serum Albumin by Application

11 Company Profiles
11.1 Albumedix
11.1.1 Albumedix Company Details
11.1.2 Company Business Overview
11.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Albumedix Recombinant Human Serum Albumin Products Offered
11.1.5 Albumedix Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Recombinant Human Serum Albumin Products Offered
11.2.5 Merck Recent Development
11.3 Ventria (InVitria)
11.3.1 Ventria (InVitria) Company Details
11.3.2 Company Business Overview
11.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered
11.3.5 Ventria (InVitria) Recent Development
11.4 NCPC
11.4.1 NCPC Company Details
11.4.2 Company Business Overview
11.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2014-2019)
11.4.4 NCPC Recombinant Human Serum Albumin Products Offered
11.4.5 NCPC Recent Development
11.5 Oryzogen
11.5.1 Oryzogen Company Details
11.5.2 Company Business Overview
11.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Oryzogen Recombinant Human Serum Albumin Products Offered
11.5.5 Oryzogen Recent Development
11.6 HiMedia
11.6.1 HiMedia Company Details
11.6.2 Company Business Overview
11.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2014-2019)
11.6.4 HiMedia Recombinant Human Serum Albumin Products Offered
11.6.5 HiMedia Recent Development

12 Future Forecast
12.1 Recombinant Human Serum Albumin Market Forecast by Regions
12.1.1 Global Recombinant Human Serum Albumin Sales Forecast by Regions 2019-2025
12.1.2 Global Recombinant Human Serum Albumin Revenue Forecast by Regions 2019-2025
12.2 Recombinant Human Serum Albumin Market Forecast by Type
12.2.1 Global Recombinant Human Serum Albumin Sales Forecast by Type 2019-2025
12.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Type 2019-2025
12.3 Recombinant Human Serum Albumin Market Forecast by Application
12.4 North America Recombinant Human Serum Albumin Forecast
12.5 Europe Recombinant Human Serum Albumin Forecast
12.6 Asia Pacific Recombinant Human Serum Albumin Forecast
12.7 Central & South America Recombinant Human Serum Albumin Forecast
12.8 Middle East and Africa Recombinant Human Serum Albumin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Human Serum Albumin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Albumedix、Merck、Ventria (InVitria)、NCPC、Oryzogen、HiMedia

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 組換型ヒト血清アルブミンの世界市場インサイト・予測(~2025年)(Global Recombinant Human Serum Albumin Market Insights, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。